New Alzheimer's Treatment: Anavex's Blarcamesine Success
Category: Stocks Total Views: 126By : Addison Perry Updated: 07-29-2024
Anavex Life Sciences Reports Promising Results for Alzheimer's Treatment
From its Phase IIb/III study on blarcamesine (ANAVEX®2-73), a medication for early Alzheimer's disease (AD), Anavex Life Sciences Corp. (Nasdaq: AVXL) has reported encouraging findings. Leading neurology specialist Dr. Marwan Noel Sabbagh delivered the data at the 2024 Alzheimer's Association International Conference (AAIC). Taken once daily, blarcamesine has shown great promise in halting the... Read More
Windtree's Latest Advances: Istaroxime Clinical Trials
Category: Stocks Total Views: 251By : Lucas Young Updated: 07-28-2024
Windtree Therapeutics Updates Istaroxime Clinical Development and Trial Data
Providing a thorough update on the clinical and business development of istaroxime, Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company committed to developing creative therapies for critical diseases, has This first-in-class treatment seeks to raise blood pressure, preserve or increase renal function, and strengthen systolic contraction and diastolic relaxation of the heart. In three Ph... Read More
BurgerFi Resolves Lawsuit, Plans Strategic Expansion
Category: Stocks Total Views: 207By : Owen Jenkins Updated: 07-28-2024
BurgerFi International Settles Litigation with Lion Point Capital
The owner of Anthony's Coal Fired Pizza & Wings and BurgerFi brand, BurgerFi International, Inc. (NASDAQ: BFI, BFIIW), revealed a sizable settlement with Lion Point Capital, LP. This agreement settles all outstanding claims brought by Lion Point against BurgerFi since the litigation started.
BurgerFi will pay Lion Point $1,350,000 in installments per terms of the settlement. BurgerFi will also issu... Read More
Small-Cap Stocks and Dow Outperform Amid Market Rebound
Category: Stocks Total Views: 190By : Addison Perry Updated: 07-25-2024
Wall Street Indexes Rebound on Strong GDP Data
Thursday's main indexes on Wall Street climbed in response to better than expected GDP data. While the Dow and small-cap stocks lagged, the Nasdaq and S&P corrected early losses. After the tech mauling of the last session, this rise brought relief. On route to recoup Wednesday's losses, the Russell 2000 jumped 2%. Investors questioned whether the recent turn to underperformance made sense. Most megacap stocks were set to p... Read More
Magnificent Seven Stocks Hit Hard by Earnings Reports
Category: Stocks Total Views: 681By : Lucas Young Updated: 07-25-2024
Tech Giants' Earnings Disappoint, Sparking Market Selloff
Significant market selloff was started by Tesla and Alphabet's latest earnings releases. Investors worried about Tesla's lowest quarterly profit margin in five years. Anxiety about growing AI infrastructure costs and YouTube competition eclipsed Alphabet's better-than-expected earnings. With a tech-heavy Nasdaq Composite falling 3.6%, its worst day since October 2022. The S&P 500 likewise slumped 2.3%. T... Read More